Your browser doesn't support javascript.
loading
Insights into the early use of oral semaglutide in routine clinical practice: The IGNITE study.
Aroda, Vanita R; Faurby, Mads; Lophaven, Søren; Noone, Josh; Wolden, Michael Lyng; Lingvay, Ildiko.
Afiliação
  • Aroda VR; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Faurby M; Novo Nordisk A/S, Søborg, Denmark.
  • Lophaven S; Omicron ApS, Roskilde, Denmark.
  • Noone J; Novo Nordisk, Plainsboro Township, New Jersey, USA.
  • Wolden ML; Novo Nordisk A/S, Søborg, Denmark.
  • Lingvay I; Department of Internal Medicine/Endocrinology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Diabetes Obes Metab ; 23(9): 2177-2182, 2021 09.
Article em En | MEDLINE | ID: mdl-34060209

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article